Skip to main content
Deletion of 22q11.2 leads to a wide variety of anomalies including congenital heart disease, palatal abnormalities, submucosal cleft palate and cleft palate, characteristic facial features and learning difficulties. Most idividuals have an immune deficiency regardless of their clinical presentation. Additional findings include: hypocalcemia, significant feeding problems, renal anomalies, hearing loss (both conductive and sensorineural), laryngotracheoesophageal anomalies, growth hormone deficiency, autoimmune disorders, seizures (without hypocalcemia), and skeletal abnormalities.